Generics 121

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vildagliptin manufacturers

121 products found

Filters

121 products found

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
DCP successful, RMS SE
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

vildagliptin + metformin

Tablets 50 mg + 500 mg, 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Libya, Saudi Arabia, South Korea
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 8 days

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Libya, Saudi Arabia, South Korea
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 8 days

vildagliptin + metformin

Tablets 50mg + 850mg, 50mg + 1000mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #392
A pharmaceutical manufacturer based in the EU that has been active in 10+ countries selling its products in Europe, and CIS for 50+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main dosage forms include solid, liquid, and semi-liquid forms.

Manufacturer usually replies in 8 days

vildagliptin

Tablets 50mg x60, x56

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #392
A pharmaceutical manufacturer based in the EU that has been active in 10+ countries selling its products in Europe, and CIS for 50+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main dosage forms include solid, liquid, and semi-liquid forms.

Manufacturer usually replies in 8 days

vildagliptin + metformin

Tablets 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 7 days

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Galvus® (Novartis)
Manufacturer #10578

Manufacturer usually replies in 6 days

vildagliptin + losartan

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Comments
Dossier availability date: Q4 2024
Manufacturer #2346

Manufacturer usually replies in 7 days

vildagliptin + metformin

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

vildagliptin

Capsules 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

vildagliptin

Tablets, film coated 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica
Registered in
Switzerland
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

vildagliptin

Tablets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Registered in
Spain
MAs for sale
Spain
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

vildagliptin + metformin

Tablets 50 mg + 1000 mg, 50 mg + 850 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Spain
Available for
Licensing with supply
MAs for sale
Spain
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

vildagliptin + metformin

Tablets, film coated 50 mg + 500 mg, 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Vietnam
Manufacturer #361
It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

vildagliptin + metformin hydrochloride

Tablets 50 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18268

Manufacturer usually replies in 4 days

vildagliptin

Tablets 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #18268

Manufacturer usually replies in 4 days

vildagliptin

Tablets 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
EU GMP
Unavailable markets
Bahrain , Egypt , Kuwait , Lebanon , Libya , Oman , Qatar , Saudi Arabia , United Arab Emirates , Yemen
Manufacturer #624

Manufacturer usually replies in 4 days

Want to view all 121 products? Create your free account today!

Vildagliptin Manufacturers

What is Vildagliptin?

Vildagliptin is an anti-diabetic agent that is used to treat type 2 diabetes. The drug is sold in the form of 100mg and 50mg oral tablets. This pharmaceutical substance was first approved by the FDA and the EMA in 2007. It is presently approved in over 70 countries and is available in both generic and trade name versions. Until patent expiry, the sole marketing authorization holder of this medicine was supplier Novartis, who distributed it under the trade name Galvus. Although it remains the most popular This variant available, other major manufacturers and suppliers, such as Mylan (Xiliarx) and Merck (Jalra) have already entered the market with their formulations. Certain suppliers also market as a combination drug along with the ingredient metformin. The most popular trade name drugs with this formulation are Eucras, Zomarist, and Galvusmet, which are all manufactured and supplied by Novartis. Competitors Mylan and Merck, however, have also introduced their own metformin variants (branded as Icandra and Jarla-M respectively). Some of the leading manufacturing companies of these medicine include Hikal, Megafine, and Chengda Pharmaceuticals. It is one of the drugs that belong to the class: dipeptidyl peptidase 4 (DPP-4) inhibitors, also known colloquially as 'gliptins'. Other active agents in this class include but are not limited to Sitagliptin (e.g. marketed by manufacturer Merck & Co. as Januvia), Linagliptin (e.g. marketed by manufacturer Boehringer Ingelheim as Tradjenta), and many more.

How Does Vildagliptin Works?

Vildagliptin improves glucose tolerance in people with type 2 diabetes by increasing the glucose responsiveness of beta-cells (-cells) in the pancreas and encouraging glucose-dependent insulin production. GLP-1 increases the sensitivity of alpha cells to glucose, which promotes glucagon production. Incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) regulate blood sugar levels and preserve glucose homeostasis. GLP-1 and GIP activity are thought to account for more than 70% of the insulin release to an oral glucose load. They enhance insulin release via G-protein-coupled GIP or GLP-1 transmitter activation in a carbohydrate manner. GLP-1 is implicated in increasing islet neogenesis and differentiation, as well as reducing pancreatic beta-cell death, in addition to its effects on insulin production. Extra-pancreatic impacts of incretin hormones include lipogenesis and cardiac function. GLP-1 production is hindered in type 2 diabetes mellitus, while GIP's insulinotropic action is greatly reduced. Vildagliptin works by blocking dipeptidyl peptidase-4 (DPP-4), a protein that rapidly downscales and deactivates GLP-1 and GIP after they are released from the intestinal epithelium. Following the second amino acid from the N-terminal end, DPP-4 cleaves oligopeptides. DPP-4 suppression extends the half-life of GLP-1 and GIP, resulting in higher quantities of active circulation in the renin-angiotensin system. It inhibits DPP-4 for a different amount of time depending on the dosage. It lowers HbA1c and glycated hemoglobin. It boosts glucose-dependent insulin production and improves alpha- and testing phase glucose tolerance. Fasting and postoperative glucose levels have dropped, and postprandial blood lipids absorption is better.

The Wholesale Price Of Vildagliptin

Vildagliptin can be purchased at any pharmacy store but prices differ from pharmacy to pharmacy. Based on the drugstore you go to, a stock of oral medication 50 mg costs roughly $40 for a supply of 100. Retail prices on order for 60 50mg tablets of this pharmaceutical remedy fall into an approximate range of 30 EUR – 40 EUR. Costs for sale are only applicable for cash-paying consumers and do not apply to insurance plans. Pharmaceutical corporations generally fund patient assistance programs, which provide free or subsidized drugs to low-income, unemployed, or under-insured patients who meet certain criteria.

Navigating Our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Empagliflozin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Vildagliptin manufacturers and Vildagliptin suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Empagliflozin. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Empagliflozin is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Vildagliptin manufacturers or Vildagliptin suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Empagliflozin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.